02.06.2013 Views

Drug Eruption and Interactions - PHARMACEUTICAL REVIEW

Drug Eruption and Interactions - PHARMACEUTICAL REVIEW

Drug Eruption and Interactions - PHARMACEUTICAL REVIEW

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

350 MEROPENEM<br />

Injection-site pain<br />

(2000): Lowe MN+, <strong>Drug</strong>s 60(3), 619<br />

(1999): Norrby SR+, Sc<strong>and</strong> J Infect Dis 31(1), 3 (1%)<br />

(1995): Geroulanos SJ, J Antimicrob Chemother 36 Suppl A, 191<br />

Injection-site reactions<br />

(1997): Hemsell DL+, Clin Infect Dis 24 Suppl 2, S222<br />

Serum sickness<br />

(2003): Ralph ED+, Clin Infect Dis 36(11), E149<br />

MESALAMINE<br />

Synonyms: 5-aminosalicylic acid; 5-ASA; fisalamine; mesalazine<br />

Trade names: Asacol (Procter & Gamble); Asacolitin; Canasa<br />

(Axcan); Claversal; Mesalazine; Mesasal; Pentasa (Shire); Pentasa<br />

SR; Quintasa; Rowasa (Solvay); Salofalk; Tidocol<br />

Indications: Ulcerative colitis<br />

Category: Aminosalicylate<br />

Half-life: 0.5–1.5 hours<br />

Reactions<br />

Skin<br />

Acne (1.2%)<br />

Allergic granulomatous angiitis (Churg–Strauss syndrome)<br />

(2006): Sinico RA+, Clin Exp Rheumatol 24(2), S104<br />

Allergic reactions (sic) (

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!